T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris

J Invest Dermatol. 2023 Aug;143(8):1340-1341. doi: 10.1016/j.jid.2023.02.002. Epub 2023 Mar 21.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Immunologic Factors
  • Pemphigus* / drug therapy
  • Rituximab / therapeutic use
  • SARS-CoV-2
  • T-Lymphocytes

Substances

  • Rituximab
  • Immunologic Factors